Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis

Clinical Rheumatology

Volumn 23, Issue 4, 2004, Pages 362-363

  Uthman, Imad ^a   Khalil, Ismail ^a   Sawaya, Raja ^a   Taher, Ali ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antiphospholipid syndrome; Cerebral venous thrombosis; Factor V Leiden; Lupus anticoagulant; Systemic lupus erythematosus; Thrombophilia

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CHLOROQUINE; DICLOFENAC; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTEIN C; PROTEIN S;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; JUGULAR VEIN; LEBANON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PHLEBOGRAPHY; PRIORITY JOURNAL; RASH; SOUTHERN EUROPE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 4444301709     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0893-8     Document Type: Article

References (10)

1. Sanna G, Bertolaccini ML, Cuadrado MJ, Khamashta MA, Hughes GR (2003) Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 42:200-213
2. Levine SR, Kieran S, Puzio K, Feit H, Patel SC, Welch KM (1987) Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. Stroke 18:801-804
3. Tomer Y, Kessler A, Eyal A, Many A, Shoenfeld Y (1991) Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol 18:95-97
4. Cervera R, Piette JC, Font J et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019-1027
5. Deschiens MA, Conard J, Horellou MH et al. (1996) Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724-1730
6. Carhuapoma JR, Mitsias P, Levine SR (1997) Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 28:2363-2369
7. Kenet G, Sadetzki S, Murad H et al. (2000) Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31:1283-1288
8. Chopra N, Koren S, Greer WL et al. (2002) Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies. J Rheumatol 29:1683-1688
9. Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A (2001) High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 86:723-724
10. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY (2000) The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 65:45-49